MediciNova is a La Jolla, California drug developer working on experimental treatments for diseases such as multiple sclerosis and ALS. It last closed at $1.31 on Nov 20, up 3.15% on the day. For the quarter ended Sep 2026, MNOV reported EPS of -$0.06 on revenue of $138,555, with revenue up 12.4% from a year ago. Over the last 12 months MNOV insiders bought $0 of stock on the open market and sold $1.7M, according to SEC Form 4 filings.
AI Auto Pilots
Is MNOV in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold MNOV.
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha callBullish64%
OPTIONS
+2
DARK POOL
+1
HISTORY
0
TECHNICAL
+1
StreetAlpha's call on MNOVStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in
MNOV · as of the Nov 20 close · updated each morning
Turning down, nearing oversold
The stock is 7% below its 20 day and 33% below its 50 day average. It is 14% below its 200 day average, so the longer trend is down. Momentum is fading (RSI 36), near oversold. The nearest support is the Pivot at $1.30, and the nearest resistance the Pivot R1 at $1.33.
Short trendBearish
Long trendNeutral
MomentumFading
StretchNear oversold
VolatilityNormal, 6.7%/day
Key levels
$3.9052 week high+197.7%
$1.7450 day average+32.8%
$1.58100 day average+20.6%
$1.49200 day average+13.7%
$1.4020 day average+6.9%
$1.37Swing high (Jun 23)+4.6%
$1.33Pivot R1+1.5%
$1.31Last close
$1.30Pivot−0.8%
$1.30Swing low (Aug 14)−0.8%
$1.28Pivot S1−2.3%
$1.2252 week low−6.9%
Indicators
RSI (14)
36.29
Weak, oversold below 30
Neutral
MACD
-0.08
Below its signal line
Bearish
Stochastic
15.1
Near the bottom of its range
Oversold
ADX (14)
12.9
No clear trend
Williams %R
-82.6
Oversold below −80, overbought above −20
Oversold
CCI (20)
-172.9
Oversold below −100, overbought above 100
Oversold
Rate of change
−10.3%
Change over 10 sessions
Bearish
ATR (14)
$0.09
Typical daily range, 6.7% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
Downtrend
Short trendBearish
Long trendBearish
MomentumWeak
StretchNormal
VolatilityHigh, 22.0%/day
Key levels
$3.9052 week high+197.7%
$1.7450 day average+32.8%
$1.58100 day average+20.6%
$1.49200 day average+13.7%
$1.4020 day average+6.9%
$1.37Swing high (Jun 23)+4.6%
$1.33Pivot R1+1.5%
$1.31Last close
$1.30Pivot−0.8%
$1.30Swing low (Aug 14)−0.8%
$1.28Pivot S1−2.3%
$1.2252 week low−6.9%
Indicators
RSI (14)
45.05
Middle of its range
Neutral
MACD
-0.01
Below its signal line
Bearish
Stochastic
3.9
Near the bottom of its range
Oversold
ADX (14)
30.3
Trending up
Williams %R
-98.1
Oversold below −80, overbought above −20
Oversold
CCI (20)
-60.8
Oversold below −100, overbought above 100
Neutral
Rate of change
−27.6%
Change over 10 sessions
Bearish
ATR (14)
$0.29
Typical daily range, 22.0% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
What happened before, for MNOV
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how MNOV did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.
November seasonalityHow MNOV usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.
Whale options flow for MNOVHow many large options trades hit MNOV, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in
No whale options trades in MNOV in the last 90 days.
From SEC Form 4 filings by MNOV's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.
AI Auto Pilots
Paper trading
StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether MNOV is in one of them and how their past MNOV trades turned out.
MediciNova is a biopharmaceutical company based in La Jolla, California. It develops drug candidates for serious diseases that lack adequate treatment options. Its main candidates are MN-166, also called ibudilast, which is being studied for conditions such as progressive multiple sclerosis and amyotrophic lateral sclerosis, and MN-001, also called tipelukast, which is being studied for fibrotic and metabolic disorders such as fatty liver disease. The company's commercial focus is the United States market.